Gemcitabine, capecitabine and oxaliplatin with or without cetuximab in advanced biliary tract carcinoma

Authors

  • Finn Ole Larsen Department of Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark and
  • Dan Taksony Solyom Hoegdall Department of Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark and
  • Estrid Hoegdall Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Dorte Nielsen Department of Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark and

DOI:

https://doi.org/10.3109/0284186X.2015.1080858

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2016-03-03

How to Cite

Ole Larsen, F., Solyom Hoegdall, D. T., Hoegdall, E., & Nielsen, D. (2016). Gemcitabine, capecitabine and oxaliplatin with or without cetuximab in advanced biliary tract carcinoma. Acta Oncologica, 55(3), 382–385. https://doi.org/10.3109/0284186X.2015.1080858

Issue

Vol. 55 No. 3 (2016): Acta Oncologica

Section

Articles